Publications – Page 7 – Experts Recherche Lymphome

Calym 2017_Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.

Kassambara A, Jourdan M, Bruyer A, Robert N, Pantesco V, Elemento O, Klein B, Moreaux J.

2017. Jun 2;45(10):5639-5652. En savoir plus

Calym 2018_SAMHD1 acts at stalled replication forks to prevent induction of interferon.

Coquel F#, Silva M-J#, Técher H#, Zadorozhny K, Sushma S, Nieminuszczy J, Mettling C, Dardillac E, Barthe A, Schmitz AL, Promonet A, Cribier A, Sarrazin A, Niedzwiedz W, Lopez B, Costanzo V, Krejci L, Chabes A, Benkirane M, Lin YL* and Pasero P*

Nature, 557, 57-61. En savoir plus

Calym 2019_EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation.

Herviou L, Jourdan M, Martinez AM, Cavalli G, Moreaux J.

Leukemia. 2019. Aug;33(8):2047-2060. En savoir plus

2019_CSF1R and BTK inhibitions as novel strategies to disrupt the dialogue between mantle cell lymphoma and macrophages

Papin A, Tessoulin B, Bellanger C, Moreau A, Le Bris Y, Maisonneuve A, Moreau P, Touzeau C, Amiot M, Pellat-Deceunynck C, Le Gouill S, Chiron D.

Leukemia. 2019 33(10):2442-2453. En savoir plus

Calym 2018_Whole Exon Sequencing of Human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.

Tessoulin B, Moreau-Aubry A, Descamps G, Gomez-Bougie P, Maiga S, Gaignard A, Chiron D, Ménoret E, Le Gouill S, Moreau P, Amiot M, Pellat-Deceunynck C.

J Hematol Oncol. 2018, 11:137 En savoir plus

Calym 2018_p53 regulates CD46 expression and Measles virus infection in myeloma cells.

Lok A, Descamps G, Tessoulin B, Chiron D, Eveillard M, -, Le Bris Y, Vabret A, Bellanger C, --- Le Gouill S, Moreau P, Tangy F, Amiot M, Moreau-Aubry A, Pellat-Deceunynck C

Blood Adv. 2018; 2:3492-3505. En savoir plus

Lysa 2018_BH3 mimetic toolkit guides the respective use of BCL2 and MCL1 BH3 mimetics in myeloma treatment.

Gomez-Bougie P, Maiga S, Tessoulin B, Bourcier J, Bonnet A, Rodriguez M, Le Gouill S, Touzeau C, Moreau P, Pellat-Deceunynck C, Amiot M.

Blood 2018;132: 2656-2669 En savoir plus

Calym 2016_Microenvironment-dependent proliferation and mitochondrial priming loss in mantle cell lymphoma is overcome by anti-CD20.

Chiron D, Bellanger C, Papin A, Tessoulin B, Dousset C, Maiga S, Moreau A, Esbelin J, Trichet V, Chen-Kiang S, Moreau P, Touzeau C, Le Gouill S, Amiot M, Pellat-Deceunynck C.

Blood. 2016; 128:2808-2818 En savoir plus

Lysa 2020_LYSA_Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma

Jaffe ES, Ashar BS, Clemens MW, Feldman AL, Gaulard P, Miranda RN, Sohani AR, Stenzel T, Yoon SW

J Clin Oncol. 2020 Apr 1;38(10):1102-1111. doi: 10.1200/JCO.19.02778. En savoir plus

Lysa 2019_LYSA_PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Delarue R, Farhat H, Quittet P, Berriolo-Riedinger A, Tempescul A, Edeline V, Maisonneuve H, Fornecker LM, Lamy T, Delmer A, Dartigues P, Martin L, André M, Mounier N, Traverse-Glehen A, Meignan M

https://www.ncbi.nlm.nih.gov/pubmed/30658935

Lysarc 2020_LYSA_The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL

Sarit Assouline, Shen Li, Christian Gisselbrecht, Patrick Fogarty, Annette Hay, Eric van den Neste, Lois E. Shepherd, Norbert Schmitz, Tara Baetz, Armand Keating, Sue Robinson, Matthew Seftel, Caterina Stelitano, Marina S. Djurfeldt, Ralph Meyer, Bingshu E. Chen, and Michael Crump

https://pubmed.ncbi.nlm.nih.gov/

Lysa 2020_LYSA_Combining Gene Expression Profiling and Machine Learning to Diagnose B-cell non-Hodgkin Lymphoma

Victor Bobée, Fanny Drieux, Vinciane Marchand, Vincent Sater, Liana Veresezan, Jean-Michel Picquenot, Pierre-Julien Viailly, Marie-Delphine Lanic, Mathieu Viennot, Elodie Bohers, Lucie Oberic, Christiane Copie-Bergman, Thierry Jo Molina, Philippe Gaulard, Corinne Haioun, Gilles Salles, Hervé Tilly, Fabrice Jardin, Philippe Ruminy

https://www.ncbi.nlm.nih.gov/pubmed/32444689

Lysa 2020_LYSA_Lenalidomide Maintenance for Diffuse Large B-cell Lymphoma Patients Responding to R-CHOP: Quality of Life, Dosing, and Safety Results From the Randomised Controlled REMARC Study

Catherine Thieblemont, Susannah Howlett, René-Olivier Casasnovas, Nicolas Mounier, Aurore Perrot, Franck Morschhauser, Christophe Fruchart, Nicolas Daguindau, Koen van Eygen, Lucie Obéric, Reda Bouabdallah, Gian Matteo Pica, Emmanuelle Nicolas-Virezelier, Julie Abraham, Olivier Fitoussi, Sylvia Snauwaert, Jean-Claude Eisenmann, Pauline Lionne-Huyghe, Dominique Bron, Sabine Tricot, Dries Deeren, Hugo Gonzalez, Régis Costello, Katell Le Du, Maria Gomes da Silva, Sebastian Grosicki, Judith Trotman, John Catalano, Dolores Caballero, Richard Greil, Amos M Cohen, Philippe Gaulard, Louise Roulin, Kenichi Takeshita, Marie-Laure Casadebaig, Hervé Tilly, Bertrand Coiffier

Br J Haematol. 2020 Apr;189(1):84-96. doi: 10.1111/bjh.16300. En savoir plus

Lysa 2020_LYSA_High Total Metabolic Tumor Volume at Baseline Predicts Survival Independent of Response to Therapy

Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loic Chartier, Christophe Fruchart, Louise Roulin, Lucie Oberic, Gian Matteo Pica, Vincent Ribrag, Julie Abraham, Marc Simon, Hugo Gonzalez, Reda Bouabdallah, Olivier Fitoussi, Catherine Sebban, Armando López-Guillermo, Laurence Sanhes, Franck Morschhauser, Judith Trotman, Bernadette Corront, Bachra Choufi, Sylvia Snauwaert, Pascal Godmer, Josette Briere, Gilles Salles, Philippe Gaulard, Michel Meignan, Catherine Thieblemont

Blood 2020 Apr 16;135(16):1396-1405. doi: 10.1182/blood.2019003526 En savoir plus

Lysa 2020_LYSA_Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

Bailly C, Carlier T, Berriolo-Riedinger A, Casasnovas O, Gyan E, Meignan M, Moreau A, Burroni B, Djaileb L, Gressin R, Devillers A, Lamy T, Thieblemont C, Hermine O, Kraeber-Bodéré F, Le Gouill S, Bodet-Milin C

Haematologica. 2020 Jan;105(1):e33-e36. doi: 10.3324/haematol.2019.223016 En savoir plus

Lysa 2020_LYSA_REALYSA : une cohorte française multicentrique en vie réelle de patients adultes atteints d’un lymphome

H. Ghesquières, A. Bernier, F. Cherblanc, A. Belot, S. Le Guyader-Peyrou, A. Monnereau

Correspondances en Onco-Hématologie N° 4 / sept. 2020 En savoir plus

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K, Benchalal M, Moles MP, Le Gouill S, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuillez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V; LYSA Group.

Blood 2018 Jan 11;131(2):174-181

Through the Glass Ceiling.

Tilly H, Salles G, Molina TJ, Casasnovas RO, Morschhauser F, Coiffier B

J Clin Oncol. 2018 Jan 25:JCO2017763961

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.

Cabannes-Hamy A, Peyrade F, Jardin F, Emile JF, Delwail V, Mounier N, Haioun C, Perrot A, Fitoussi O, Lara D, Delarue R, André M, Offner F, Ghesquières H, Pascal L, Soussain C, Lazarovici J, Schiano JM, Gaulard P, Tilly H, Thieblemont C; LYSA; lymphoma study association.

Cancer Med 2018 Feb 23. doi: 10.1002/cam4.1139

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Huet S, Tesson B, Jais JP, Feldman AL, Magnano L, Thomas E, Traverse-Glehen A, Albaud B, Carrère M, Xerri L, Ansell SM, Baseggio L,Reyes C, Tarte K, Boyault S, Haioun C, Link BK, Feugier P, Lopez-Guillermo A, Tilly H, Brice P, Hayette S, Jardin F, Offner F, Sujobert P, Gentien D, Viari A, Campo E, Cerhan JR, Salles G

ncet Oncol. 2018 Feb 20. pii: S1470-2045(18)30102-5

From genetics to the clinic: a translational perspective on follicular lymphoma

Huet S, Sujobert P, Salles G

Nat Rev Cancer. 2018 Feb 9. doi: 10.1038/nrc.2017.127

Bendamustine-Based conditioning prior to ASCT: Results of a French Multicenter Study of 474 Patients from LYSA Centers.

Chantepie SP, Garciaz S, Tchernonog E, Peyrade F, Larcher MV, Diouf M, Fornecker LM, Houot R, Gastinne T, Soussain C, Malak S, Lemal R, Delette C, Ibrahim A, Gac AC, Reboursière E, Vilque JP, Bekadja MA, Casasnovas RO, Gressin R, Guidez S, Coso D, Herbaux C, Bouabdallah K, Durot E, Damaj G.

Am J Hematol 2018 Feb 23. doi: 10.1002/ajh.25077

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin’s lymphoma in the standard arm of H10 trial.

Cottereau AS, Versari A, Loft A, Casasnovas O, Bellei M, Ricci R, Bardet S, Castagnoli A, Brice P, Raemaekers J, Deau B, Fortpied C, Raveloarivahy T, Van Zele E, Chartier L, Vander Borght T, Federico M, Hutchings M, Ricardi U, Andre M, Meignan M

Blood 2018 Feb 1. pii: blood-2017-07-795476.

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.

Wang M, Rule S, Zinzani PL, Goy A, Casasnovas O, Smith SD, Damaj G, Doorduijn J, Lamy T, Morschhauser F, Panizo C, Shah B, Davies A, Eek R, Dupuis J, Jacobsen E, Kater AP, Le Gouill S, Oberic L, Robak T, Covey T, Dua R, Hamdy A, Huang X, Izumi R, Patel P, Rothbaum W, Slatter JG, Jurczak W.

Lancet 2018 Feb 17;391(10121):659-667. doi: 10.1016/S0140-6736(17)33108-2

Publications scientifiques sur le lymphome